DaVita announces Joel Ackerman to be CFO
Mr. Ackerman is chief executive officer and a board member at Champions Oncology, a company engaged in the development of advanced technology solutions and services to personalize the development and use of oncology drugs, and has been in that role since 2010.
Prior to Champions Oncology, Mr. Ackerman was at Warburg Pincus from 1993 to 2008, a private equity firm, where he was a partner and headed up the healthcare services group.
Mr. Ackerman has served on the board of directors of Kindred Healthcare since 2008, and served on the board of directors of Coventry Health Care.
He earned a bachelor's degree from Columbia University, where he graduated summa cum laude, and a master's degree in Physics from Harvard University.
Jim Hilger, who has served as the company's interim chief financial officer since 2015, will continue in his role as chief accounting officer, a position he has held since 2010. ■
What to read next
LATEST MOVES FROM Colorado
- Zayo Group appoints Matt Steinfort as CFO
- Chipotle Mexican Grill names Laurie Schalow CCO
- ENSERVCO appoints Tucker Franciscus as CFO
- Array BioPharma appoints Shalini Sharp to board
- Zayo Group appoints Andrew Crouch as COO
More inside POST
DP World EBITDA margin was 53.4 Earnings